المؤلفون: Cristina Suarez, Mario Sznol, Richard W. Joseph, Beiying Ding, Ning Leng, Alain Ravaud, John D. Hainsworth, Thomas E. Hutson, Brian I. Rini, David F. McDermott, Sergio Bracarda, Sumanta K. Pal, Allen Lee Cohn, Thomas Powles, Walter M. Stadler, James A. Reeves, Mahrukh Huseni, Christina Schiff, Lawrence Fong, Bernard Escudier, Kenji Hashimoto, Toni K. Choueiri, Michael B. Atkins, Robert J. Motzer

المصدر: European Urology. 79:665-673

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, Oncology, medicine.medical_specialty, Bevacizumab, Urology, 030232 urology & nephrology, Phases of clinical research, Antibodies, Monoclonal, Humanized, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Renal cell carcinoma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, medicine, Humans, Adverse effect, Carcinoma, Renal Cell, business.industry, Cancer, medicine.disease, Kidney Neoplasms, 030220 oncology & carcinogenesis, Disease Progression, business, Kidney cancer, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd4b5731294d1d03ff6daf0d1a9584b
https://doi.org/10.1016/j.eururo.2021.01.003

المؤلفون: Jamal Misleh, Olwen Hahn, Dean F. Bajorin, Karla A Ballman, Joel Picus, Michael J. Morris, Scott T. Tagawa, Walter M. Stadler, Susan Halabi, Jonathan E. Rosenberg, Benjamin A. Teply, Christopher Sweeney, Daniel A. Vaena, Robert Dreicer, Eric J. Small, Christopher J. Hoimes, Sreedhar Katragadda, Elizabeth R. Plimack, Pamela J. Atherton, Thomas W. Flaig, Amir Mortazavi

المصدر: J Clin Oncol

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Urologic Neoplasms, Metastatic Urothelial Carcinoma, Bevacizumab, Angiogenesis, Angiogenesis Inhibitors, Placebo, Deoxycytidine, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, In patient, Urothelial carcinoma, Aged, Cisplatin, Neovascularization, Pathologic, business.industry, ORIGINAL REPORTS, Survival Analysis, Gemcitabine, 030104 developmental biology, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7022be39528665f9ae4d7d63ccd0df2
https://pubmed.ncbi.nlm.nih.gov/35984094

المؤلفون: Motohide Uemura, Cristina Suarez, Howard Gurney, Elisabeth Piault-Louis, David F. McDermott, Elaine T. Lam, Caroleen Quach, Christina Schiff, Stéphane Oudard, Sergio Bracarda, Bernard Escudier, Qian Cindy Zhu, Carsten Grüllich, Robert J. Motzer, Beiying Ding, Frede Donskov, Michael B. Atkins, Brian I. Rini, Susheela Carroll, Walter M. Stadler, Thomas Powles

المصدر: Atkins, M B, Rini, B I, Motzer, R J, Powles, T, McDermott, D F, Suarez, C, Bracarda, S, Stadler, W M, Donskov, F, Gurney, H, Oudard, S, Uemura, M, Lam, E T, Grüllich, C, Quach, C, Carroll, S, Ding, B, Zhu, Q C, Piault-Louis, E, Schiff, C & Escudier, B 2020, ' Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma ', Clinical Cancer Research, vol. 26, no. 11, pp. 2506-2514 . https://doi.org/10.1158/1078-0432.CCR-19-2838

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Population, CANCER-PATIENTS, urologic and male genital diseases, THERAPY, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Atezolizumab, law, Internal medicine, FUNCTIONAL ASSESSMENT, medicine, 030212 general & internal medicine, education, SYMPTOM INDEX, Survival rate, education.field_of_study, Sunitinib, business.industry, Clinical trial, Regimen, 030220 oncology & carcinogenesis, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f97b77f41738e00c8827f89a7e2cea
https://pure.au.dk/portal/da/publications/patientreported-outcomes-from-the-phase-iii-randomized-immotion151-trial(0e8fcf48-68ed-46f8-903a-fd0d93d00297).html

المؤلفون: Michael B, Atkins, Brian I, Rini, Robert J, Motzer, Thomas, Powles, David F, McDermott, Cristina, Suarez, Sergio, Bracarda, Walter M, Stadler, Frede, Donskov, Howard, Gurney, Stephane, Oudard, Motohide, Uemura, Elaine T, Lam, Carsten, Grüllich, Caroleen, Quach, Susheela, Carroll, Beiying, Ding, Qian Cindy, Zhu, Elisabeth, Piault-Louis, Christina, Schiff, Bernard, Escudier

المصدر: Clin Cancer Res

مصطلحات موضوعية: Male, Middle Aged, urologic and male genital diseases, Antibodies, Monoclonal, Humanized, Kidney Neoplasms, Article, Bevacizumab, Survival Rate, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Sunitinib, Humans, Female, Longitudinal Studies, Patient Reported Outcome Measures, Carcinoma, Renal Cell, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::85581c970953c6f66a3798d53513b6d7
https://pubmed.ncbi.nlm.nih.gov/32127394

المؤلفون: Primo N. Lara, Amol Rao, Sumanta K. Pal, Mayer Fishman, Jacek K. Pinksi, James S. Hu, Walter M. Stadler, Tanya B. Dorff, Ulka N. Vaishampayan, David I. Quinn, Jeff Longmate

المصدر: Cancer. 123:4566-4573

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Angiogenesis, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, medicine, Clinical endpoint, business.industry, Cancer, Endoglin, medicine.disease, Surgery, Vascular endothelial growth factor, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug, Transforming growth factor

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e2176e1a12626e11f298a35a2f8a749e
https://doi.org/10.1002/cncr.30942

المؤلفون: Boris Alekseev, Toni K. Choueiri, Brian I. Rini, Camillo Porta, Ugo De Giorgi, Begoña Mellado, Motohide Uemura, Walter M. Stadler, Howard Gurney, Bohuslav Melichar, Alain Ravaud, David F. McDermott, Mahrukh Huseni, Robert E. Hawkins, Cristina Suarez, Elisabeth Piault-Louis, Frede Donskov, Michael B. Atkins, S. Li, Gretchen Frantz, Marjorie C. Green, Robert J. Motzer, Tarik Khaznadar, Christina Schiff, Thomas Powles, Bernard Escudier, Alpa Thobhani, Michael Staehler, Sergio Bracarda, Francis Parnis, Jae-Lyun Lee, Jens Bedke

المصدر: Rini, B I, Powles, T, Atkins, M B, Escudier, B, McDermott, D F, Suarez, C, Bracarda, S, Stadler, W M, Donskov, F, Lee, J L, Hawkins, R, Ravaud, A, Alekseev, B, Staehler, M, Uemura, M, De Giorgi, U, Mellado, B, Porta, C, Melichar, B, Gurney, H, Bedke, J, Choueiri, T K, Parnis, F, Khaznadar, T, Thobhani, A, Li, S, Piault-Louis, E, Frantz, G, Huseni, M, Schiff, C, Green, M C & Motzer, R J 2019, ' Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151) : a multicentre, open-label, phase 3, randomised controlled trial ', The Lancet, vol. 393, no. 10189, pp. 2404-2415 . https://doi.org/10.1016/S0140-6736(19)30723-8

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Bevacizumab, Population, Antineoplastic Agents, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Atezolizumab, law, Internal medicine, Sunitinib, Medicine, Humans, 030212 general & internal medicine, education, Survival rate, Carcinoma, Renal Cell, Aged, education.field_of_study, business.industry, Hazard ratio, Antibodies, Monoclonal, General Medicine, Middle Aged, Interim analysis, Kidney Neoplasms, Survival Rate, Treatment Outcome, Drug Therapy, Combination, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865a488dc3d7e34740857a03657281dc
https://pubmed.ncbi.nlm.nih.gov/31954471

المؤلفون: Suchit Jhunjhunwala, Lawrence Fong, Jiaheng Qiu, Toni K. Choueiri, James A. Reeves, Priti S. Hegde, Christina Schiff, Bernard Escudier, Viktor Gruenwald, Dorothee Nickles, Alpa Thobhani, Richard W. Joseph, Walter M. Stadler, Daniel S. Chen, Elisabeth Piault-Louis, Alain Ravaud, Riccardo Danielli, Thomas E. Hutson, John D. Hainsworth, Martin Gore, W. Kimryn Rathmell, Sergio Bracarda, Michael B. Atkins, Sumanta K. Pal, Mahrukh Huseni, Robert J. Motzer, Gregg Fine, Thomas Powles, Brian I. Rini, David F. McDermott, Mario Sznol, Cristina Suarez

المصدر: Nature medicine. 24(6)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Sunitinib, Humans, Carcinoma, Renal Cell, Aged, Aged, 80 and over, business.industry, Gene Expression Profiling, Antibodies, Monoclonal, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Immune checkpoint, Kidney Neoplasms, Angiogenesis inhibitor, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Mutation, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473ccd225ada7c2586204155b123a86b
https://pubmed.ncbi.nlm.nih.gov/30291359

المؤلفون: Tanya B, Dorff, Jeff A, Longmate, Sumanta K, Pal, Walter M, Stadler, Mayer N, Fishman, Ulka N, Vaishampayan, Amol, Rao, Jacek K, Pinksi, James S, Hu, David I, Quinn, Primo N, Lara

المصدر: Cancer. 123(23)

مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Antibodies, Monoclonal, Middle Aged, Prognosis, Carcinoma, Papillary, Kidney Neoplasms, Article, Bevacizumab, Survival Rate, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Carcinoma, Renal Cell, Aged, Follow-Up Studies, Neoplasm Staging

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::b4e2ce6ba389d96412fed4df49bfe568
https://pubmed.ncbi.nlm.nih.gov/28832978

المؤلفون: Walter M. Stadler, Karla V. Ballman, Thomas W. Flaig, Olwen Hahn, Jonathan E. Rosenberg, Susan Halabi, Robert Dreicer, Amir Mortazavi, Michael J. Morris, Colleen Watt, Preston D. Steen, Christopher Sweeney

المصدر: Journal of Clinical Oncology. 37:4503-4503

مصطلحات موضوعية: Oncology, Cisplatin, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Bevacizumab, Angiogenesis, business.industry, Placebo, Gemcitabine, Double blind, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, business, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::009acb5e5bfa971b7ec92c43fb9c145b
https://doi.org/10.1200/jco.2019.37.15_suppl.4503

المؤلفون: Sumanta K. Pal, Thomas Powles, Alpa Thobhani, Brian I. Rini, Jiaheng Qiu, Lawrence Fong, James A. Reeves, Christina Schiff, W. Kimryn Rathmell, Bernard Escudier, Priti S. Hegde, Elisabeth Piault-Louis, David F. McDermott, Sergio Bracarda, Michael B. Atkins, Toni K. Choueiri, Thomas E. Hutson, Mahrukh Huseni, Gregg Fine, Alain Ravaud, Riccardo Danielli, Martin Gore, Viktor Gruenwald, Daniel S. Chen, Robert J. Motzer, John D. Hainsworth, Richard W. Joseph, Dorothee Nickles, Walter M. Stadler, Suchit Jhunjhunwala, Mario Sznol, Cristina Suarez

المصدر: Nature Medicine. 24:1941-1941

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Sunitinib, General Medicine, medicine.disease, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Chart, Atezolizumab, Renal cell carcinoma, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::80c94a65947fadce3103d2d867208d15
https://doi.org/10.1038/s41591-018-0235-z